View in EDS

A US Retrospective Claims Analysis Comparing Healthcare Costs of Patients Transitioning from Immediate-Release Oxycodone to Two Different Formulations of Extended-Release Oxycodone: Xtampza ER or OxyContin.

Saved in:
Bibliographic Details
Title: A US Retrospective Claims Analysis Comparing Healthcare Costs of Patients Transitioning from Immediate-Release Oxycodone to Two Different Formulations of Extended-Release Oxycodone: Xtampza ER or OxyContin.
Authors: Olatoke O; HEOR Department, ZRx Outcomes Research, Mississauga, Ontario, Canada., Zah V; HEOR Department, ZRx Outcomes Research, Mississauga, Ontario, Canada., Stanicic F; HEOR Department, ZRx Outcomes Research, Mississauga, Ontario, Canada., Vukicevic D; HEOR Department, ZRx Outcomes Research, Mississauga, Ontario, Canada., Yfantopoulos P; HEOR Department, ZRx Outcomes Research, Mississauga, Ontario, Canada., Thompson C; Medical Department, Collegium Pharmaceutical Inc., Stoughton, MA, USA., DeGeorge MK; Medical Department, Collegium Pharmaceutical Inc., Stoughton, MA, USA., Passik S; Medical Department, Collegium Pharmaceutical Inc., Stoughton, MA, USA.
Source: ClinicoEconomics and outcomes research : CEOR [Clinicoecon Outcomes Res] 2022 Mar 03; Vol. 14, pp. 119-128. Date of Electronic Publication: 2022 Mar 03 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101560564 Publication Model: eCollection Cited Medium: Print ISSN: 1178-6981 (Print) Linking ISSN: 11786981 NLM ISO Abbreviation: Clinicoecon Outcomes Res Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35264862
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A US Retrospective Claims Analysis Comparing Healthcare Costs of Patients Transitioning from Immediate-Release Oxycodone to Two Different Formulations of Extended-Release Oxycodone: Xtampza ER or OxyContin.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Olatoke+O%22">Olatoke O</searchLink>; HEOR Department, ZRx Outcomes Research, Mississauga, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Zah+V%22">Zah V</searchLink>; HEOR Department, ZRx Outcomes Research, Mississauga, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Stanicic+F%22">Stanicic F</searchLink>; HEOR Department, ZRx Outcomes Research, Mississauga, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Vukicevic+D%22">Vukicevic D</searchLink>; HEOR Department, ZRx Outcomes Research, Mississauga, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Yfantopoulos+P%22">Yfantopoulos P</searchLink>; HEOR Department, ZRx Outcomes Research, Mississauga, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Thompson+C%22">Thompson C</searchLink>; Medical Department, Collegium Pharmaceutical Inc., Stoughton, MA, USA.<br /><searchLink fieldCode="AU" term="%22DeGeorge+MK%22">DeGeorge MK</searchLink>; Medical Department, Collegium Pharmaceutical Inc., Stoughton, MA, USA.<br /><searchLink fieldCode="AU" term="%22Passik+S%22">Passik S</searchLink>; Medical Department, Collegium Pharmaceutical Inc., Stoughton, MA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560564%22">ClinicoEconomics and outcomes research : CEOR</searchLink> [Clinicoecon Outcomes Res] 2022 Mar 03; Vol. 14, pp. 119-128. <i>Date of Electronic Publication: </i>2022 Mar 03 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Dove+Medical+Press%22">Dove Medical Press </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101560564 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1178-6981 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211786981%22">11786981 </searchLink><i>NLM ISO Abbreviation: </i>Clinicoecon Outcomes Res <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35264862
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2147/CEOR.S340290
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 119
    Titles:
      – TitleFull: A US Retrospective Claims Analysis Comparing Healthcare Costs of Patients Transitioning from Immediate-Release Oxycodone to Two Different Formulations of Extended-Release Oxycodone: Xtampza ER or OxyContin.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Olatoke O
      – PersonEntity:
          Name:
            NameFull: Zah V
      – PersonEntity:
          Name:
            NameFull: Stanicic F
      – PersonEntity:
          Name:
            NameFull: Vukicevic D
      – PersonEntity:
          Name:
            NameFull: Yfantopoulos P
      – PersonEntity:
          Name:
            NameFull: Thompson C
      – PersonEntity:
          Name:
            NameFull: DeGeorge MK
      – PersonEntity:
          Name:
            NameFull: Passik S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 03
              Text: 2022 Mar 03
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 1178-6981
          Numbering:
            – Type: volume
              Value: 14
          Titles:
            – TitleFull: ClinicoEconomics and outcomes research : CEOR
              Type: main
ResultId 1